Holdings
Sanofi
As of Sep 30, 2026, Sanofi reported 15 positions worth US$566M. Largest: MeiraGTx Holdings plc, Inhibrx Biosciences, Inc. and Novavax, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| MeiraGTx Holdings plc | 12.2M | US$134M | no change | Sep 30, 2026 |
| Inhibrx Biosciences, Inc. | 1.16M | US$116M | no change | Sep 30, 2026 |
| Novavax, Inc. | 6.88M | US$74.4M | no change | Sep 30, 2026 |
| Odyssey Therapeutics, Inc. | 1.99M | US$44.2M | −1,718 | Sep 30, 2026 |
| AnaptysBio, Inc. | 822K | US$41.3M | no change | Sep 30, 2026 |
| AgomAb Therapeutics NV | 2.78M | US$30.9M | new | Sep 30, 2026 |
| First Tracks Biotherapeutics, Inc. | 822K | US$29.1M | no change | Sep 30, 2026 |
| Electra Therapeutics, Inc. | 2.46M | US$27.7M | new | Sep 30, 2026 |
| Attovia Therapeutics, Inc. | 1.08M | US$18.6M | new | Sep 30, 2026 |
| Latigo Biotherapeutics, Inc. | 673K | US$11.2M | new | Sep 30, 2026 |